Publications Office of the EU
Case T-573/10: Order of the General Court of 8 March 2012 — Octapharma Pharmazeutika v EMA (Medicinal products for human use — Changes to a plasma master file (PMF) — Fees payable to the EMA — Act with adverse effects — Measure merely confirmatory — Manifest inadmissibility)
DisplayCustomHeader
MyPortal
hrvatski
BasketSummary
Web Content Display (Global)
Publication Detail Actions Portlet

Uslužni programi

Publication Detail Actions Portlet
 Ocjene korisnika
custom-survey-notification
Publication Detail Portlet

Publication detail

Home

Case T-573/10: Order of the General Court of 8 March 2012 — Octapharma Pharmazeutika v EMA (Medicinal products for human use — Changes to a plasma master file (PMF) — Fees payable to the EMA — Act with adverse effects — Measure merely confirmatory — Manifest inadmissibility)

Case T-573/10: Order of the General Court of 8 March 2012 — Octapharma Pharmazeutika v EMA (Medicinal products for human use — Changes to a plasma master file (PMF) — Fees payable to the EMA — Act with adverse effects — Measure merely confirmatory — Manifest inadmissibility)

Metapodaci o publikaciji

Publication Viewer

Preglednik dokumenata

Pop up window annotations
DisplayCustomFooter